인쇄하기
취소
|
Since the usage of pricey hepatitis C treatments, ‘Sovaldi’ and ‘Harvoni,’ rapidly increase, the pharmaceutical distribution industry the pharmacy circles have raised a voice that they would need to cooperate to solve issues.
After extension of the health insurance benefit, Sovaldi and Harvoni have created a number of issues as encroaching pharmaceutical distribution companies’ distribution co...